Table 3. The rates of antimicrobial resistance in percentages for selected Gram-positive pathogens at 47 centers according to specimens.
| Pathogen | Specimen (n) | AMP | FOX | CPT | CHL | CIP | CLI | ERY | GEN | LVX | LZD | MIN | MXF | NIT | OXA | PEN | SYN | TEC | TET | SXT | VAN |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S. aureus | All (2,646) | ND | 25.0 | 0.0 | 0.9 | 26.3 | 32.3 | 32.9 | 8.4 | 27.5 | 0.7 | 1.8 | 23.1 | 0.6 | 23.1 | 90.3 | 1.7 | 1.8 | 4.8 | 4.7 | 0.0 |
| RES (144) | ND | 21.4 | ND | ND | 22.5 | 27.5 | 27.1 | 6.6 | 22.1 | 1.1 | ND | 20.2 | 0.0 | 20.2 | 84.8 | 0.0 | ND | 6.2 | 3.0 | 0.0 | |
| URI (91) | ND | 9.1 | ND | ND | 21.4 | ND | 20.0 | ND | 20.0 | 0.0 | ND | 16.7 | 3.7 | 14.3 | 77.8 | 0.0 | ND | ND | 7.4 | 0.0 | |
| BLO (293) | ND | 16.7 | 0.0 | 10.0 | 24.4 | 28.8 | 26.9 | 10.7 | 25.4 | 1.0 | 0.0 | 19.7 | 1.6 | 18.4 | 95.6 | 5.3 | 10.0 | 4.8 | 8.7 | 0.0 | |
| E. faecalis | All (892) | 6.1 | ND | ND | ND | 35.5 | ND | 58.6 | ND | 35.8 | 7.3 | ND | ND | 3.0 | ND | 16.6 | 84.4 | ND | 80.9 | ND | 4.3 |
| URI (270) | 7.4 | ND | ND | ND | 42.4 | ND | 63.2 | ND | 41.5 | 7.5 | ND | ND | ND | ND | 20.0 | 86.5 | ND | 87.6 | ND | 5.2 | |
| BLO (30) | 3.6 | ND | ND | ND | 20.0 | ND | 38.1 | ND | 20.0 | 3.6 | ND | ND | ND | ND | 14.3 | 94.4 | ND | 83.3 | ND | 3.6 | |
| E. faecium | All (124) | 73.2 | ND | ND | ND | 60.8 | ND | 80.8 | ND | 58.4 | 2.4 | ND | ND | 17.1 | ND | 74.1 | 9.7 | ND | 47.7 | ND | 20.7 |
| URI (38) | 80.6 | ND | ND | ND | 77.8 | ND | 93.1 | ND | 72.2 | 2.8 | ND | ND | 11.4 | ND | 89.3 | 11.5 | ND | 57.7 | ND | 25.0 |
RES: respiratory (tracheal aspirate and bronchial washing), URI: urine, BLO: blood, ND: not determined, AMP: ampicillin, FOX: cefoxitin, CPT: ceftaroline, CHL: chloramphenicol, CIP: ciprofloxacin, CLI: clindamycin, ERY: erythromycin, GEN: gentamicin, LVX: levofloxacin, LZD: linezolid, MIN: minocycline, MXF: moxifloxacin, NIT: nitrofurantoin, OXA: oxacillin, PEN: penicillin, SYN: quinupristin-dalfopristin, TEC: teicoplanin, TET: tetracycline, SXT: trimethoprim-sulfamethoxazole, and VAN: vancomycin.